These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents. Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines. Oliveira VG; Dos Santos Faiões V; Gonçalves GBR; Lima MFO; Boechat FCS; Cunha AC; de Andrade-Neto VV; de C da Silva F; Torres-Santos EC; de Souza MCBV Curr Top Med Chem; 2018; 18(17):1454-1464. PubMed ID: 30277154 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold. Staderini M; Piquero M; Abengózar MÁ; Nachér-Vázquez M; Romanelli G; López-Alvarado P; Rivas L; Bolognesi ML; Menéndez JC Eur J Med Chem; 2019 Jun; 171():38-53. PubMed ID: 30904756 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo. Arruda DC; Miguel DC; Yokoyama-Yasunaka JK; Katzin AM; Uliana SR Biomed Pharmacother; 2009 Nov; 63(9):643-9. PubMed ID: 19321295 [TBL] [Abstract][Full Text] [Related]
11. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae). Grecco Sdos S; Reimão JQ; Tempone AG; Sartorelli P; Cunha RL; Romoff P; Ferreira MJ; Fávero OA; Lago JH Exp Parasitol; 2012 Feb; 130(2):141-5. PubMed ID: 22143090 [TBL] [Abstract][Full Text] [Related]
12. Structure/antileishmanial activity relationship study of naphthoquinones and dependency of the mode of action on the substitution patterns. Ali A; Assimopoulou AN; Papageorgiou VP; Kolodziej H Planta Med; 2011 Dec; 77(18):2003-12. PubMed ID: 21800278 [TBL] [Abstract][Full Text] [Related]
13. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani. Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives. Peyron C; Benhida R; Bories C; Loiseau PM Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460 [TBL] [Abstract][Full Text] [Related]
15. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes. Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation. Rodrigues RF; da Silva EF; Echevarria A; Fajardo-Bonin R; Amaral VF; Leon LL; Canto-Cavalheiro MM Eur J Med Chem; 2007 Jul; 42(7):1039-43. PubMed ID: 17367894 [TBL] [Abstract][Full Text] [Related]